Ireland vs Poland: Treatment success rate for patients treated for MDR-TB
Ireland
27.0%
in 2022
Poland
23.0%
in 2016
Ireland rank
155th
Poland rank
156th
Treatment success rate for patients treated for MDR-TB over time
- Ireland
- Poland
How they compare
Ireland currently reports 27.0% against 23.0% in Poland, a difference of 4.0%.
That makes Ireland's figure about 1.2 times Poland's.
The two have swapped places 1 time across 6 shared years of data; in 2007 it was Poland ahead.
Ireland ranks 155th and Poland ranks 156th of 163 countries.
Across the 2 decades both report, Ireland averaged higher in 1 and Poland in 1.
Head to head by decade
| Decade | Ireland | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.0% | 59.0% | 48.0% | Poland |
| 2010s | 57.4% | 22.2% | 35.2% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Ireland or Poland?
- Ireland, at 27.0% against 23.0% in Poland as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Ireland and Poland?
- 4.0%, with Ireland ahead.
- How many years of comparable data are there for Ireland and Poland?
- 6 years are reported by both, from 2007 to 2016.
- How do Ireland and Poland rank globally for treatment success rate for patients treated for mdr-tb?
- Ireland ranks 155th and Poland ranks 156th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.